T cell receptor signaling and cell immunotherapy

被引：0

作者：

Linsong Zhang ^{[1
]}

Xinyi Xu ^{[2
]}

Xiaoshan Shi ^{[1
]}

Chenqi Xu ^{[2
]}

机构：

[1] Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology,Chinese Academy of Sciences

[2] State Key Laboratory of Molecular Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, University of Chinese Academy of Sciences, Chinese Academy of

来源：

National Science Open | 2024年 / 3卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R392.12 [免疫细胞生物学];

学科分类号：

摘要：

As the major sensor of adaptive immune system, T cell receptor(TCR) can recognize diverse antigens and initiate specific immune responses against invading pathogens and cancer cells. Understanding the mechanisms of TCR signaling has led to the development of engineered T cell therapies, which have extensive applications in the treatment of diseases such as cancer, infection and autoimmunity. Here, we review the current understanding of antigen-induced TCR signaling and discuss its applications in T cell therapies.

引用

页码：156 / 171

页数：16

共 50 条

[41] THE T-CELL RECEPTOR β-CHAIN IS AN IMMUNOTHERAPY TARGET FOR LYMPHOMAS
不详
CANCER DISCOVERY, 2018, 8 (01) : 13 - 13
[42] Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Mueller, Thomas R.
Jarosch, Sebastian
Hammel, Monika
Leube, Justin
Grassmann, Simon
Bernard, Bettina
Effenberger, Manuel
Andrae, Immanuel
Chaudhry, M. Zeeshan
Kaeuferle, Theresa
Malo, Antje
Cicin-Sain, Luka
Steinberger, Peter
Feuchtinger, Tobias
Protzer, Ulrike
Schumann, Kathrin
Neuenhahn, Michael
Schober, Kilian
Busch, Dirk H.
CELL REPORTS MEDICINE, 2021, 2 (08)
[43] T-Cell Receptor Mimic Antibodies for Cancer Immunotherapy
Duan, Zhijian
Ho, Mitchell
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (09) : 1533 - 1541
[44] Chimeric Antigen Receptor T Cell Based Immunotherapy for Cancer
Li, Feng
Zhang, Tengfei
Cao, Ling
Zhang, Yi
CURRENT STEM CELL RESEARCH & THERAPY, 2018, 13 (05) : 327 - 335
[45] To affinity and beyond: Harnessing the T Cell receptor for cancer immunotherapy
Thaxton, Jessica E.
Li, Zihai
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3313 - 3321
[46] T-cell receptor peptides as immunotherapy for autoimmune disease
Gold, DP
Shroeder, K
Golding, A
Brostoff, SW
Wilson, DB
CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (5-6) : 507 - 510
[47] The T cell receptor for antigen: Signaling and ligand discrimination
Germain, RN
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (38) : 35223 - 35226
[48] Cytoskeletal adaptivity regulates T cell receptor signaling
Thauland, Timothy J.
Hu, Kenneth H.
Bruce, Marc A.
Butte, Manish J.
SCIENCE SIGNALING, 2017, 10 (469)
[49] Peeking Into the Black Box of T Cell Receptor Signaling
Weiss, Arthur
ANNUAL REVIEW OF IMMUNOLOGY, 2024, 42 : 1 - 20
[50] Regulation of T cell receptor signaling by lipid metabolites
Wang, F.
Beck-Garcia, K.
Zorzin, C.
Schamel, W.
Davis, M.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 295 - 295

← 1 2 3 4 5 →